Heron Therapeuti
Price & Volume
Stats
See more52W Range | $0.50-$3.93 |
Market Cap | $269.9M |
Shares Short | 30M |
Financials
See moreRevenue (12 Mos) | $136.3M |
Revenue Growth (YoY) | 13.4% |
Gross Profit (12 Mos) | -$50.5M |
Diluted EPS | -$0.25 |
News
See moreYahoo Finance • 9 months ago
Heron Therapeutics, Inc. (NASDAQ:HRTX) is largely controlled by institutional shareholders who own 52% of the company
Yahoo Finance • 12 months ago
Heron Therapeutics Announces Third Quarter 2023 Financial Results and Updates Financial Guidance
Yahoo Finance • 2 years ago
Why Heron Therapeutics Stock Has Been on Fire This Week
About
CEO | Mr. Craig Alexander Collard |
CFO | Ms. Ira Duarte |
Address | 4242 Campus Point Court, San Diego, CA, United States, 92121 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 126 |
